Skip to main content
. 2016 Mar 30;7(19):27445–27457. doi: 10.18632/oncotarget.8479

Figure 3. MiR-31 inhibits migration and invasion of UBC cells.

Figure 3

(A) T24 and 5637 cells were either without transfection (blank control) or transfected with miR-NC or miR-31, and then subjected to wound healing assay to determine the migration capacity at 24 h and 48 h following scarification, respectively. (B) Transwell assay was performed to evaluate the invasion capacity of UBC cells at 24 h after seeded onto the upper chamber. (C) Measurement of wound closure based on initial and residual (48 h) gap lengths in wound healing assay (left panel, relative to blank control group), and quantification of invaded cells in transwell assay (right panel); data are presented as mean ± SEM; *P < 0.05; **P < 0.01.